HD Hyundai hosts Future Tech Forum in Gyeongju on the 27th, the first official session for APEC 2025 Korea Chairman Chung emphasized the need for shipbuilding innovation; inviting partnering companies as speakers Forum covered issues on next-generation defense technologies, AI and digital transformation, robotics, and Korea–U.S. shipbuilding cooperation SEOUL, South Korea, Oct. 26, 2025 /PRNewswire/ -- HD Hyundai opened APEC 2025 Korea by presenting a blueprint for the future of shipbuilding in collaboration with global leaders.

SEOUL, South Korea, Oct. 26, 2025 /PRNewswire/ -- UniPin, the leading digital entertainment enabler in Southeast Asia and India, hosted a seminar in Seoul titled "Expanding Beyond Borders: Real-Life Insights to Grow Your Business in SEA & India" on October 23 in Gangnam, South Korea. The event brought together over 50 professionals from Korea's gaming and digital content industries, offering direct, data-backed insights into two of the fastest-growing gaming markets in the world.

SINGAPORE, Oct. 26, 2025 /PRNewswire/ -- impress.ai today announced the launch of Savos, a revolutionary AI-powered hiring ally designed to solve one of the most pressing challenges in modern recruitment: disconnected hiring. Savos is a sophisticated multi-agent system that seamlessly connects recruiters, hiring managers, and candidates, streamlining communication and improving two key metrics that matter most: time from application to interview and interview-to-hire ratio.

Setting new standards in responsible innovation, CSL's Broadmeadows facility blends Pharma 4.0™ principles with sustainable design to transform plasma manufacturing BROADMEADOWS, AUSTRALIA, Oct. 26, 2025 /PRNewswire/ -- CSL's base fractionation facility in Broadmeadows, Australia has been recognised as the Overall Winner of the 2025 Facility of the Year Award (FOYA) by the International Society for Pharmaceutical Engineering (ISPE).

WILMINGTON, Del., Oct. 26, 2025 /PRNewswire/ -- UGREEN, a leading innovator in consumer electronics, is excited to announce that its NASync DXP2800 will arrive in 460 Walmart stores across the United States. UGREEN has always been committed to providing innovative and high-quality products to consumers worldwide. The entry of our NASync products into Walmart's stores is a significant milestone in UGREEN's expansion into the United States market.

ZHANGJIAGANG, China, Oct. 26, 2025 /PRNewswire/ -- On October 24, the 2025 Yangtze River Cultural Festival formally began in Zhangjiagang, Jiangsu Province, celebrating the region's deep cultural heritage and creative vitality. Co-hosted by the Publicity Department of the CPC Jiangsu Provincial Committee, the Jiangsu Provincial Department of Culture and Tourism, and the People's Government of Suzhou City, the event was co-organized by the Publicity Department of the CPC Suzhou Municipal Committee, …

HONG KONG, Oct. 26, 2025 /PRNewswire/ -- As a key gateway for fostering connectivity, Hong Kong is set to accelerate the integrated development of the Guangdong-Hong Kong-Macao Greater Bay Area and the nation's high-quality growth. The city will achieve this by continuously channeling global capital, promoting innovation and building cultural bridges, senior officials, industry leaders and experts told the Greater Bay Area Conference 2025, which was held on Thursday in the Hong Kong Special Administrative Region.

BEIJING, Oct. 26, 2025 /PRNewswire/ -- Langjiu, a leading Chinese baijiu brand, has held the "Chinese Langjiu, Welcoming the World" event in Italy from October 20 to 23. During the event, Langjiu has participated in the Global Fashion Summit 2025 held in Milan, Italy, from October 21 to 22, as the exclusive liquor partner, highlighting the cultural charm of Chinese baijiu on the international stage.

HONG KONG, Oct. 26, 2025 /PRNewswire/ -- NetDragon Websoft Holdings Limited ("NetDragon" or "the Company"; Hong Kong Stock Code: 777), a global leader in building internet communities, is pleased to announce that it has signed a strategic Memorandum of Understanding ("MOU") with Open University Malaysia ("OUM") in Fuzhou, Changle. This collaboration marks a major step forward in integrating the strengths of both parties in open education and digital technology to explore how artificial intelligence …

SHANGHAI and HONG KONG, Oct. 26, 2025 /PRNewswire/ -- Antengene Corporation Limited ("Antengene", SEHK: 6996.HK), a leading innovative, commercial-stage global biotech company dedicated to discovering, developing and commercialising first-in-class and/or best-in-class medicines for autoimmune disease, solid tumors and hematological malignancies indications, today announced that the latest preclinical data of ATG-201 (CD19 x CD3 TCE) were presented in a Poster Presentation at the 2025 American …

SAN DIEGO, Oct. 26, 2025 /PRNewswire/ -- Today, the American Transportation Research Institute (ATRI), the trucking industry's not-for-profit research organization, released its 21st annual Top Industry Issues report that identifies the trucking industry's leading issues. This year's list includes the Economy, Lawsuit Abuse Reform, Insurance Cost and Availability, and Truck Parking. The list also debuts four first-time issues including English Language Proficiency for Drivers and Artificial Intelligence …

GUANGZHOU, China, Oct. 26, 2025 /PRNewswire/ -- At Phase 2 of the 138th Canton Fair, the Gardening Products and Weaving, Rattan & Iron Products sections are attracting strong interest for their focus on practical aesthetics, merging everyday functionality with artistry and sustainable design. Exhibitors are demonstrating how craftsmanship and green innovation can elevate the beauty and usability of modern living spaces. A leading exhibitor in eco-friendly garden supplies has transformed nearly its entire booth into a display of new products, with 90% of the showcased …

SINGAPORE and AUSTIN, Texas, Oct. 26, 2025 /PRNewswire/ -- Augmentus, the Singapore-based pioneer in AI-robotics and adaptive automation, today announced a strategic investment from Applied Ventures, LLC, the venture capital arm of Applied Materials, Inc. This investment marks a significant milestone in Augmentus' mission to enable intelligent, autonomous robotics for high-mix, high-variability manufacturing across the globe.

The proportion of participants achieving HbA1c < 7.0% and a ≥10% reduction in body weight from baseline was 48.0% in the mazdutide group and 21.0% in the semaglutide group DREAMS-3 is the world's first Phase 3 clinical trial of a GCG/GLP-1 dual receptor agonist to conduct a head-to-head comparison with semaglutide in diabetes treatment SAN FRANCISCO and SUZHOU, China, Oct. 26, 2025 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncologic, autoimmune, cardiovascular and metabolic, ophthalmologic and other major diseases, announces that the fourth Phase 3 clinical trial DREAMS-3 of mazdutide, a glucagon-like peptide-1 (GLP-1) and glucagon (GCG) dual receptor agonist, has met its primary endpoint. The results demonstrated that, in Chinese patients with type 2 diabetes (T2D) and obesity, mazdutide showed superior efficacy to semaglutide on the primary endpoint—the proportion of participants achieving HbA1c < 7.0% and ≥10% body weight reduction from baseline at week 32 (48.0 vs. 21.0%, p

The company presented the 'AIN Family' which consists of NAND solution products optimized for performance(P), bandwidth(B), and density(D) respectively for AI SK hynix held 'HBF Night' to expand the 'AIN B'(HBF product) ecosystem with a number of global big tech officials in attendance Company will collaborate closely with customers and partners to become a key player in the next generation NAND storage market

Long-term data shows significant and sustained blood pressure reductions in both office-based and 24-hour ambulatory blood pressure, reinforcing the durability, safety and effectiveness of the Symplicity™ blood pressure procedure in patients prescribed antihypertensive medications GALWAY, Ireland, Oct. 26, 2025 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced new, long-term results from its final report of the SPYRAL HTN-ON MED randomized clinical trial, showing that patients treated with the Symplicity™ Spyral renal denervation (RDN) procedure experienced significantly greater reductions in blood pressure compared to sham patients through three years. The data were presented as part of Featured Clinical Research during the 2025 …

NEW YORK, Oct. 26, 2025 /PRNewswire/ --  Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of LifeMD, Inc. (NASDAQ: LFMD) between May 7, 2025 and August 5, 2025, both dates inclusive (the "Class Period"), of the important October 27, 2025 lead plaintiff deadline in the securities class action first filed by the Firm.

CESSA Phase 3 Clinical Trial Results Earn ACG Presidential Poster Distinction Among Nearly 6,000 Abstracts Next-generation Hydrocortisone Acetate (ngHCA™) Suppository Administered with Sephure® Suppository Applicator Demonstrates Statistically Significant Rates of Clinical Remission in Patients with UC in CESSA Phase 3 Trial Additional Findings Reinforce Rapid and Sustained Drug Release of ngHCA

SELUTION DeNovo Trial - the largest randomized Drug Eluting Balloon trial - demonstrates a SELUTION SLR™ DEB strategy is non-inferior to a Drug Eluting Stent treatment strategy in de novo lesions. SELUTION4ISR, a randomized controlled trial, proves SELUTION SLR™ DEB is an alternative to current standard of care for In-Stent Restenosis (ISR) treatment.

Novartis to acquire Avidity for USD 72.00 per share in cash for total equity value of approximately USD 12.0 billion  Avidity expects to separate its early-stage precision cardiology programs into a new company ("SpinCo") Closing expected in 1H2026 subject to completion of the separation of SpinCo from Avidity and other customary closing conditions